Efficacy of osimertinib in a metastatic lung adenocarcinoma patient harboring somatic EGFR delL747_S752 and germline BIM deletion polymorphism: a case report and literature review

BACKGROUND: Epidermal growth factor receptor (EGFR) exon 19 deletion (19del) and the exon 21 L858R point mutation are the most established predictive factors for the efficacy of EGFR-tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer (NSCLC). To date, more than 50 subtypes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wenyu, Niu, Niu, Zeng, Jialong, Ke, Xianni, Jin, Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641130/
https://www.ncbi.nlm.nih.gov/pubmed/36388025
http://dx.doi.org/10.21037/tcr-22-1050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641130/
https://www.ncbi.nlm.nih.gov/pubmed/36388025
http://dx.doi.org/10.21037/tcr-22-1050

Ejemplares similares